GAMMA Investing’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Buy
12,378
+2,614
+27% +$211K 0.04% 384
2026
Q1
$690K Sell
9,764
-2,643
-21% -$198K 0.03% 457
2025
Q4
$979K Buy
12,407
+759
+7% +$60.1K 0.05% 317
2025
Q3
$959K Buy
11,648
+36
+0.3% +$2.83K 0.05% 303
2025
Q2
$934K Buy
11,612
+1,450
+14% +$112K 0.06% 287
2025
Q1
$816K Buy
10,162
+984
+11% +$81.8K 0.06% 282
2024
Q4
$751K Buy
9,178
+1,855
+25% +$154K 0.06% 265
2024
Q3
$604K Buy
7,323
+1,672
+30% +$125K 0.06% 288
2024
Q2
$397K Buy
5,651
+1,665
+42% +$119K 0.05% 318
2024
Q1
$295K Buy
3,986
+591
+17% +$41.2K 0.06% 302
2023
Q4
$235K Buy
+3,395
New +$212K 0.06% 276

Other funds holding MET

GAMMA Investing's MET Position: Q2 2026 in Review

GAMMA Investing increased its MetLife (MET) stake by 27% in Q2 2026, buying an estimated $211K and bringing the position to 12,378 shares worth $1.05M. The position accounts for 0.04% of the portfolio, ranked #384.

GAMMA Investing first reported a position in MET in Q4 2023 and has held it in 11 quarters since. 374 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • GAMMA Investing held 12,378 shares of MetLife worth $1.05M as of Q2 2026.
  • GAMMA Investing bought 2,614 MetLife shares in Q2 2026, an estimated $211K.
  • MetLife made up 0.04% of GAMMA Investing's portfolio in Q2 2026, its #384 holding.
  • GAMMA Investing first reported a position in MetLife in Q4 2023 and has held it in 11 quarters since.
  • 374 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.